Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor

Researchers provided genetic evidence that Pleckstrin-2 deficiency largely reverted tumorigenesis in Pten prostate-specific knockout mice.